These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23194750)

  • 1. Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K/Akt inhibition in vascular smooth muscle cells.
    Sinagra T; Tamburella A; Urso V; Siarkos I; Drago F; Bucolo C; Salomone S
    Biochem Pharmacol; 2013 Feb; 85(4):551-9. PubMed ID: 23194750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
    Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
    Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
    Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
    Xiao Y; Yuan T; Yao W; Liao K
    FEBS J; 2010 Feb; 277(3):687-96. PubMed ID: 20050918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
    Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
    Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modulation of vascular ATP-sensitive K+ channel function via the phosphatidylinositol 3-kinase-Akt pathway activated by phenylephrine.
    Haba M; Hatakeyama N; Kinoshita H; Teramae H; Azma T; Hatano Y; Matsuda N
    J Pharmacol Exp Ther; 2010 Aug; 334(2):673-8. PubMed ID: 20519555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension.
    Zhang L; Xie P; Wang J; Yang Q; Fang C; Zhou S; Li J
    J Biol Chem; 2010 Apr; 285(18):13666-77. PubMed ID: 20212046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.
    Yuan Y; Zhang A; Huang S; Ding G; Chen R
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F393-402. PubMed ID: 21123490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
    Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
    Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension.
    Budzyn K; Marley PD; Sobey CG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1248-53. PubMed ID: 15743931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, induces dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels.
    Omae T; Nagaoka T; Tanano I; Yoshida A
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6749-56. PubMed ID: 21757589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neither K+ channels nor PI3K/Akt mediates the vasodilative effect of nebivolol on different types of rat arteries.
    Wang Y; Zhang M; Liu Y; Li J; Song E; Niu L; Cheng N
    J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):332-8. PubMed ID: 19903983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ang II attenuates IGF-1-stimulated Na+, K(+)-ATPase activity via PI3K/Akt pathway in vascular smooth muscle cells.
    Isenovic ER; Meng Y; Jamali N; Milivojevic N; Sowers JR
    Int J Mol Med; 2004 Jun; 13(6):915-22. PubMed ID: 15138635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pioglitazone and rosiglitazone on aortic vascular function in rat genetic hypertension.
    Llorens S; Mendizabal Y; Nava E
    Eur J Pharmacol; 2007 Dec; 575(1-3):105-12. PubMed ID: 17803988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
    Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
    J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
    Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
    BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.
    Chan KC; Wu CH; Huang CN; Lan KP; Chang WC; Wang CJ
    Cardiovasc Ther; 2012 Apr; 30(2):75-84. PubMed ID: 20946258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of insulin signaling on vascular smooth muscle cell migration, proliferation, and inflammation pathways.
    Cersosimo E; Xu X; Musi N
    Am J Physiol Cell Physiol; 2012 Feb; 302(4):C652-7. PubMed ID: 22094332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of PPARγ agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia.
    Kim M; Lee EJ; Shin HM; Jung HS; Kim TK; Kim TN; Kwon MJ; Lee SH; Rhee BD; Park JH
    J Endocrinol Invest; 2017 Oct; 40(10):1069-1076. PubMed ID: 28391584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
    Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
    Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.